column
    Serum Containing Ethanol Extract of Akebia Trifoliate (Thunb.) Koidz Regulates Proliferation and Apoptosis of BEL-7404 Cells by Inhibiting Glycolysis
    WANG Chunling, ZHENG Zuowen, MO Siping, WEN Xiaodong
    2022, 39(18): 2301-2308. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.001
    Abstract PDF
    Study on Intervention Effect and Mechanism of Zuogui Jiangtang Jieyu Formula on Microglia Activation in Simulated Diabetic Depression
    MENG Pan, Xiang Yun, LEI Chang, WANG Yuhong, HUANG Dan, CAI Chuan, ZHANG Xiuli
    2022, 39(18): 2309-2315. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.002
    Abstract PDF
    Screening of Inhibiting-cholinesterase Active Fractions from Forsythia Suspensa Leaves
    DANG Li, MA Hong, DU Huizhi
    2022, 39(18): 2316-2321. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.003
    Abstract PDF
    Quality Evaluation of 3D Printing Clarithromycin Gastric-floating Sustained-release Tablets
    CHEN Peihong, LIU Zhiting, HUANG Siyu, CHEN Yanzhong, LYU Zhufen, XIE Qingchun
    2022, 39(18): 2322-2327. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.004
    Abstract PDF
    Investigation on the Key Factors of Affecting in Vitro Release of Losartan Potassium and Hydrochlorothiazide Tablets
    FU Fangfang, ZHAO Zhouming, ZHU Junmin, YUAN Bo, XIE Wenyu, TENG Zheyi, GUO Xiaodi
    2022, 39(18): 2328-2333. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.005
    Abstract PDF
    Comparison of Process Technology for Perillae Fructus Formula Granules with Different Pretreatment Processes
    LEI Chengkang, GAO Lin, SI Malei, HUANG Ping, SHAN Min
    2022, 39(18): 2334-2338. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.006
    Abstract PDF
    Study on Simultaneous Determination of 9 Components in Eclipta Herba from Different Growing Areas by QAMS Method and It’s Quality Evaluation
    LIU Yingxin, FENG Chuanping, LIU Lili, KONG Xingxin, TIAN Qingqing
    2022, 39(18): 2339-2346. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.007
    Abstract PDF
    Content Determination of Nine Components in Gastrodiae Rhizoma and Analysis of Different Components Between Wild and Cultivated Species
    PEI Wenhan, LI Siyu, SONG Huanjie, YU Xiaojing, ZHANG Hui
    2022, 39(18): 2347-2353. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.008
    Abstract PDF
    Determination of vonoprazan and Metabolite Vonoprazan Carboxylic Acid(M1) by UPLC-MS/MS and its application to pharmacokinetic study in rats Plasma
    XU Haibo, WANG Shuanghu, LIN Nengming, ZHOU Yunfang
    2022, 39(18): 2354-2359. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.009
    Abstract PDF
    Establishment of Internal Quality Control Evaluation Method of Therapeutic Drug Monitoring of Methotrexate Based on Westgard Multi-rule Theory
    ZHU Junfeng, SUN Jiao, LEI Yingqiong, ZHONG Like, FANG Luo
    2022, 39(18): 2360-2366. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.010
    Abstract PDF
    Study on Efficacy Evaluation and Potential Mechanism of Shenfukang Capsule in Treatment to Chronic Glomerulonephritis by Meta Analysis and Network Pharmacology
    FU Yi, LI Xin, WEI Lin, WU Zhaodong, CHEN Bangming, FU Yi, LIU Yongfang
    2022, 39(18): 2367-2376. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.011
    Abstract PDF
    Analysis of Professor Chen Zhe’s medication rule in differentiation and treatment of rectal cancer based on Data Mining
    PAN Bo, NIE Shuchang, XU Xiaowan, HONG Jing, FENG qiuting, LIU qun, ZHAI Xiaofeng
    2022, 39(18): 2377-2381. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.012
    Abstract PDF
    Study on Prescription Analysis of Proton Pump Inhibitors Switch of 19 254 Outpatients
    REN Weifang, LIU Yujuan
    2022, 39(18): 2382-2386. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.013
    Abstract PDF
    Clinical Cases Analysis of Furazolidone-induced Acute Pulmonary Toxicity
    SHEN Qi, LI Zhijun, WANG Fei, HAN Qi, LI Li
    2022, 39(18): 2387-2391. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.014
    Abstract PDF
    Formation Analysis and Actual Challenges of National Drug Sampling and Testing Program from the Perspective of Risk Management
    XI Hao, ZHU Jiong, WANG Chong
    2022, 39(18): 2396-2404. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.017
    Abstract PDF
    Current Situation and the Trend of Clinical Trials of Drugs for Treatment of Multiple Sclerosis
    WANG Jiaying, RUAN Zourong, JIANG Bo
    2022, 39(18): 2405-2411. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.018
    Abstract PDF
    Research Progress of Antiviral Activity of Quercetin and Its Derivatives
    SHI Zhiheng, ZENG Jialin, HUANG Xinru, PENG Yuhan, SU Weiwei, WANG Yonggang
    2022, 39(18): 2412-2420. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.019
    Abstract PDF
    Research Progress of Nanotechnology in Diagnosis and Treatment of Atherosclerosis
    GAO Linyu, HE Qingqing, ZHU Ling, ZHANG Huijuan
    2022, 39(18): 2421-2428. DOI: 10.13748/j.cnki.issn1007-7693.2022.18.020
    Abstract PDF